Caffarel et al. (2010) reported that JWH133 mitigated tumor growth, tumor number, and the severity of lung metastases in MMTV-neu mice, a clinically relevant model of ErbB2-driven metastatic breast cancer. This evidence concerns the gene ERBB2 and neoplasm.